Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · IEX Real-Time Price · USD
3.55
+0.19 (5.65%)
At close:
Mar 17, 2023, 4:00 PM
3.50
-0.05 (-1.41%)
Pre-market:
Mar 20, 2023, 8:47 AM EDT
Income Statement (Annual)
Financials in millions CAD. Fiscal year is November - October.
Millions CAD. Fiscal year is Nov - Oct.
| Year | 2022 | 2021 | 2020 |
|---|---|---|---|
| Selling, General & Admin | 4.33 | 3.03 | 0.23 |
| Research & Development | 4.21 | 0.65 | 0 |
| Operating Expenses | 8.53 | 3.68 | 0.23 |
| Operating Income | -8.53 | -3.68 | -0.23 |
| Interest Expense / Income | 0.02 | 0 | 0 |
| Other Expense / Income | 0.82 | 0.04 | 0.18 |
| Pretax Income | -9.37 | -3.72 | -0.41 |
| Income Tax | 0.04 | 0 | 0 |
| Net Income | -9.41 | -3.72 | -0.41 |
| Shares Outstanding (Basic) | 1 | 1 | 1 |
| Shares Outstanding (Diluted) | 1 | 1 | 1 |
| Shares Change | 40.19% | 70.50% | - |
| EPS (Basic) | -7.24 | -4.01 | -0.76 |
| EPS (Diluted) | -7.24 | -4.01 | -0.76 |
| Free Cash Flow Per Share | -3.92 | -3.09 | -0.51 |
| EBITDA | -9.24 | -3.72 | -0.41 |
| Depreciation & Amortization | 0.11 | 0 | 0 |
| EBIT | -9.35 | -3.72 | -0.41 |
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).